Valiant Laboratories Limited IPO : All You Need to Know

Valiant Laboratories Limited IPO is set to launch on 27 September, 2023. The company initiated its business operations in the year 1980. It is a pharmaceutical ingredient manufacturing company and is focused on manufacturing paracetamol. The company’s manufacturing facility is located in Maharashtra. It is spread in 2000 sq mtrs and has an annual capacity of 9000 MT. It imports PARA AMINO PHENOL which is the raw material for manufacturing paracetamol. This is done though China and Cambodia for cheaper purchase cost. The company currently employees 86 people.

Valiant Laboratories Limited IPO DETAILS

Valiant Laboratories Limited IPO is set to launch on 27 September, 2023. The subscription timeline extends till 3 October, 2023. The size for the IPO is 152.46 Crore Rs. Shares issued through fresh issue mode are worth 152.46 Crore Rs. No shares are Issued through offer for sale mode. The lot size is 105 shares and the price is 133 to 140 Rs per share. The company is going to get listed at both NSE and BSE. The face value per share is Rs.10 and this is a Book Built issue. The registrar for the company is Link Intime India Private Limited.

Tabular Description of Valiant Laboratories Limited IPO

IPO OPENING DATE	27 September, 2023
CLOSING DATE FOR IPO	3 October, 2023
ISSUE TYPE	Book Built Issue
Face Value per share	10 Rs. per share
IPO price band	133 Rs. to 140 Rs. per share
LOT SIZE	105 shares
MINIMUM ORDER QUANTITY	105 shares
ISSUE SIZE	152.46 Crore Rs.
OFFER FOR SALE	No shares are issued through offer for sale mode
FRESH ISSUE	152.46 Crore Rs.
LISTING AT	NSE, BSE
LISTING DATE	9 October, 2023

Valiant Laboratories Limited IPO : IMPORTANT DATES

IPO OPENING DATE	27 September, 2023
CLOSING DATE FOR IPO	3 October, 2023
IPO ALLOTMENT DATE	5 October, 2023
REFUNDS	6 October, 2023
DEMAT A/C CREDITED ON	6 October, 2023
IPO LISTING DATE	9 October, 2023

Valiant Laboratories Limited IPO begins for subscription from 27 September 2023. The IPO subscription would continue till 3 October, 2023. The allotment status for the shareholders who applied would come on 5 October, 2023. The refunds for the ones who did not get allotment would be initiated on 6 October, 2023. The DEMAT accounts of shareholders would be credited on 6 October, 2023. The listing of the company would be completed on 9 October, 2023.

Valiant Laboratories Limited IPO : Lead Managers

The lead managers are :

• Unistone Capital Private Limited

The minimum lot size for the company is decided at 105 shares. This holding accounts to 14700 Rs.. The maximum lot size is decided at 1365 shares. This amounts to 191100 Rs.. Hence the company’s final holdings would be set as :

	Shares	Amount
Minimum	105 shares	14700 Rs.
Maximum	1365 shares	191100 Rs.

OBJECTIVES FOR THE IPO

• IPO proceeds would be used for general corporate purposes.
• The company will use the IPO money for further working capital requirements.
• IPO proceeds will be used for investment into VASPL (a subsidiary of the company).
• The company wants to pay the outstanding through the IPO Money.

COMPANY FINANCIALS

Particularly (in Crore Rs.)	2020-21	2021-22	2022-23
ASSETS	106	181	212
Revenue	183	293	338
PAT	30	27	29

Valiant Laboratories Limited had an asset base of 106 Crore Rs in the year 2021. This increased to 181 Crore Rs in the year 2022 and 212 Crore Rs in the year 2023. The revenue of the company is 183 Crore Rs for the year 2021. This increased to a mega 293 Crore Rs in the next year. The revenue for the year 2023 was 338 Crore Rs. The company has been low on the profit achievement. The profit of the company was 30 Crore Rs in 2021. This decreased to 27 Crore Rs in 2022. Further on the profit increased to 29 Crore Rs in 2023 as compared to 2022. However the profit of the year 2023 is still lower than the 30 Crore achieved in 2021.

PROS

• The company’s manufacturing facility is located in Maharashtra. It is spread in 2000 sq mtrs and has an annual capacity of 9000 MT.
• It imports PARA AMINO PHENOL which is the raw material for manufacturing paracetamol. This is done though China and Cambodia for cheaper purchase cost.
• The company currently employees 86 people.

CONS

• The company works in a highly competitive segment.

Valiant Laboratories Limited IPO Application Process with Zerodha

It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :

1. Logging into Zerodha console through its website or KITE platform. Clicking the IPO section present in the ORDER tab.
2. Click the Valiant Laboratories Limited IPO button and press the BID button.
3. Entering the details asked for like UPI ID, Quantity and price.
4. Submit the application form for the IPO.
5. Visiting the application of UPI for approving the transaction.

Now, applying for an IPO online is possible with most of the Discount and online brokers.